Chemotherapy of advanced transitional-cell carcinoma of the bladder

Abstract

A number of single agents and multidrug combinations are useful in the therapy of advanced transitional-cell carcinoma of the bladder. Phase II studies have identified cisplatin, Adriamycin (doxorubicin), methotrexate, and vinblastine as the most active cytotoxic agents. Combination chemotherapy based on cisplatin has shown greater efficacy than older… (More)
DOI: 10.1007/BF00686953

4 Figures and Tables

Topics

  • Presentations referencing similar topics